We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

THC and CBD Can Reduce Neural Activity in Juvenile Zebrafish, Study Finds

As zebrafish are accepted models for humans in scientific research (much like mice), the authors of the study say that these observed effects of prenatal cannabis exposure could be mirrored in humans.

Read More

Harsh European Cannabis Laws Don’t Deter Frequent Consumers, Study Finds

The researchers found that while restrictive intervention does appear to decrease the share of adolescents initiating cannabis use, there was no evidence of policy changes impacting the share of frequent cannabis users.

Read More

How Can Centrifugal Partition Chromatography Separate Pesticides From Cannabis? A Q&A with RotaChrom Technologies

The cannabis sector has a growing interest in centrifugal partition chromatography (CPC). To find out more about this process and its future potential, Analytical Cannabis spoke with the head of a research laboratory at one of the leading CPC instrument manufacturers, RotaChrom Technologies.

Read More

Gibraltar Industries, Nexus, RBI, and Processing Brands Unify as Prospiant

Analytical Cannabis caught up with Prospiant, a leading US-based provider of “soil-to-oil” cannabis ecosystems for the cultivation, extraction, and refinement of cannabinoids.

Read More

MDMA-assisted Therapy Can Successfully Treat PTSD, Study Finds

The use of MDMA-assisted therapy for post-traumatic stress disorder (PTSD) has now proven itself in its first phase 3 clinical trial.

Read More

How to Ensure Quality Control in Cannabis-infused Products

Cannabis-infused foods, drinks, lotions, and tinctures are growing in popularity. But how can producers guarantee they'll be made safely and reliably? Analytical Cannabis spoke to several manufacturers to find out.

Read More

Parental Consumption Shapes How Teens Use Cannabis

Research shows understanding teen use helps develop effective prevention programs.

Read More

Older Adults with Functional Impairments Linked to Prescription Drug Misuse

Study finds adults age 50 and older with functional impairments use medical cannabis more and are more likely to suffer from prescription opioid and tranquilizer/sedative use and misuse.

Read More

FDA Grants Authorization Allowing Research Institute to Study Psychedelic Use by Therapists

This comes after the FDA also recently allowed institutes to conduct clinical trials on MDMA and its therapeutic potential in treating PTSD.

Read More

 
Advertisement